High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma

被引：38

作者：

Aoki, T. ^{[1
,2
]}

Shimada, K. ^{[2
]}

Suzuki, R. ^{[3
]}

Izutsu, K. ^{[4
]}

Tomita, A. ^{[2
]}

Maeda, Y. ^{[5
]}

Takizawa, J. ^{[6
]}

Mitani, K. ^{[7
]}

Igarashi, T. ^{[8
]}

Sakai, K. ^{[9
,10
]}

Miyazaki, K. ^{[11
]}

Mihara, K. ^{[12
]}

Ohmachi, K. ^{[13
]}

Nakamura, N. ^{[14
]}

Takasaki, H. ^{[15
]}

Kiyoi, H. ^{[2
]}

Nakamura, S. ^{[16
,17
]}

Kinoshita, T. ^{[18
]}

Ogura, M. ^{[1
,19
]}

机构：

[1] Nagoya Daini Red Cross Hosp, Dept Hematol & Oncol, Nagoya, Aichi, Japan

[2] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi 4648601, Japan

[3] Shimane Univ Hosp, Canc Ctr, Izumo, Shimane, Japan

[4] Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan

[5] Okayama Univ Hosp, Dept Hematol & Oncol, Okayama, Japan

[6] Niigata Univ, Fac Med, Dept Hematol Endocrinol & Metab, Niigata, Japan

[7] Dokkyo Med Univ, Sch Med, Dept Hematol & Oncol, Mibu, Tochigi, Japan

[8] Gunma Canc Ctr, Dept Hematol & Oncol, Ota, Japan

[9] Shinshu Univ, Sch Med, Dept Biomed Lab Sci, Matsumoto, Nagano 390, Japan

[10] Shinshu Univ, Sch Med, Dept Hematol, Matsumoto, Nagano 390, Japan

[11] Mie Univ, Grad Sch Med, Dept Hematol & Oncol, Tsu, Mie 514, Japan

[12] Hiroshima Univ Hosp, Dept Hematol, Hiroshima, Japan

[13] Tokai Univ, Dept Hematol, Isehara, Kanagawa, Japan

[14] Tokai Univ, Dept Pathol, Isehara, Kanagawa, Japan

[15] Kanagawa Canc Ctr, Dept Med Oncol, 1-1-2 Nakao, Yokohama, Kanagawa 2410815, Japan

[16] Nagoya Univ Hosp, Dept Pathol, Nagoya, Aichi, Japan

[17] Nagoya Univ Hosp, Clin Labs, Nagoya, Aichi, Japan

[18] Aichi Canc Ctr, Dept Hematol & Cell Therapy, Nagoya, Aichi 464, Japan

[19] Tokai Cent Hosp, Dept Hematol, Kakamigahara, Japan

来源：

BLOOD CANCER JOURNAL | 2015年 / 5卷

关键词：

RITUXIMAB; THERAPY;

D O I：

10.1038/bcj.2015.101

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：e372 / e372

页数：5

共 50 条

[1] High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma
T Aoki
K Shimada
R Suzuki
K Izutsu
A Tomita
Y Maeda
J Takizawa
K Mitani
T Igarashi
K Sakai
K Miyazaki
K Mihara
K Ohmachi
N Nakamura
H Takasaki
H Kiyoi
S Nakamura
T Kinoshita
M Ogura
[J]. Blood Cancer Journal, 2015, 5 : e372 - e372
[2] High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma
Alkhaldi, Hanan
Reinhardt, Alec
Barnett, Melissa
Kundu, Suprateek
Hosing, Chitra
Ramdial, Jeremy
Saini, Neeraj
Srour, Samer
Alousi, Amin
Kebriaei, Partow
Popat, Uday
Qazilbash, Muzaffar
Champlin, Richard
Shpall, Elizabeth J.
Gulbis, Allison
Shigle, Terri Lynn
Dabaja, Bouthaina
Pinnix, Chelsea
Ahmed, Sairah
Steiner, Raphael
Andersson, Borje S.
Nieto, Yago
[J]. TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (11): : 690 - 694
[3] Salvage chemotherapy and autologous stem cell transplantation are inferior for relapsed or refractory primary mediastinal large B-cell lymphoma compared with diffuse large B-cell lymphoma
Kuruvilla, John
Pintilie, Melania
Tsang, Richard
Nagy, Tracy
Keating, Armand
Crump, Michael
[J]. LEUKEMIA & LYMPHOMA, 2008, 49 (07) : 1329 - 1336
[4] High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma
Rancea, Michaela
Monsef, Ina
von Tresckow, Bastian
Engert, Andreas
Skoetz, Nicole
[J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (06):
[5] High-dose chemoadiotherapy followed by autologous peripheral blood stem cell transplantation in patients with primary mediastinal large B-cell lymphoma.
He, XH
Shi, YK
Han, XH
Zhou, AP
Zhou, SY
Liu, P
Yan, JL
Feng, FY
[J]. BLOOD, 2003, 102 (11) : 295B - 295B
[6] High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: Prognostic features and outcomes
Engelhardt, Brian G.
Holland, Derek W.
Brandt, Stephen J.
Chinratanalab, Wichai
Goodman, Stacey A.
Greer, John P.
Jagasia, Madan H.
Kassim, Adetola A.
Morgan, David S.
Ruffner, Katherine L.
Schuening, Friedrich G.
Wolff, Steven
Bitting, Rhonda
Sulur, Paulgun
Stein, Richard S.
[J]. LEUKEMIA & LYMPHOMA, 2007, 48 (09) : 1728 - 1735
[7] High-dose rituximab in combination with autologous stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma
Shi, Yi-Fen
Zhou, Shu-Juan
Sun, Lan
Yu, Kang
Chen, Yi
[J]. MEDICINA CLINICA, 2020, 155 (06): : 235 - 241
[8] Outcomes of salvage chemotherapy and autologous stem cell transplantation for relapsed or refractory primary mediastinal large B cell lymphoma are not inferior to bulky diffuse large B cell lymphoma
Kuruvilla, J
Nagy, T
Pintilie, M
Keating, A
Crump, M
[J]. ANNALS OF ONCOLOGY, 2005, 16 : 100 - 100
[9] Role of high-dose chemotherapy and autologous stem cell transplantation in patients with diffuse large B-cell lymphoma
Gavrilina, O. A.
Gabeeva, N. G.
Morozova, A. K.
Sidorova, A. A.
Zvonkov, E. E.
[J]. TERAPEVTICHESKII ARKHIV, 2013, 85 (07): : 90 - 97
[10] High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation As a Salvage Treatment in Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma
Hyung, Jaewon
Hong, Jung Yong
Yoon, Dok Hyun
Kim, Shin
Park, Jung Sun
Park, Chan-Sik
Lee, Sang Wook
Ryu, Jin-Sook
Huh, Jooryung
Suh, Cheolwon
[J]. BLOOD, 2018, 132

← 1 2 3 4 5 →